The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

Doug Doran was one of hundreds of men in Bendigo diagnosed with prostate cancer last year, and with the number of cases ...

JAMAICANS are being encouraged to screen for colorectal cancer, as it continues to be an increasing cause of death on the ...

A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...

"Key Takeaways" There are many soy myths, especially about breast cancer and how it may impact hormones. Other myths say soy ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The antibody-drug conjugate FOR46 showed the strong potential of using CD46 as a new therapeutic target in metastatic ...

As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...

The Food and Drug Administration (FDA) has expanded the approval of Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) to include patients with ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...